For gut-targeted use, where oral's local delivery is efficient, oral can be very cost-effective
7,8 Many case series, however, diagnosed AIG solely based on serological markers such as IFAs or PCAs, pepsinogen levels or gastrin-17, without confirmatory biopsy
[10] Long-term use of proton pump inhibitors (PPIs) and H2-receptor antagonists reduces gastric acid, potentially impairing the release of B12 from dietary proteins
Subchronic and chronic toxicity studies extending up to several months of continuous BPC-157 administration reveal no significant organ toxicity, hematological abnormalities, or pathological changes in treated animals compared to controls
Standard protocols for martial artists involve 0.25 to 0.5 mg daily via subcutaneous injection near the injury site for 4 to 8 weeks